Edition:
India

Akorn Inc (AKRX.OQ)

AKRX.OQ on NASDAQ Stock Exchange Global Select Market

32.37USD
22 Nov 2017
Change (% chg)

-- (--)
Prev Close
$32.37
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
565,457
52-wk High
$33.99
52-wk Low
$17.61

Latest Key Developments (Source: Significant Developments)

Fresenius confirms discussions concerning potential acquisition of Akorn
Saturday, 8 Apr 2017 

Fresenius Se : Co and Akorn Inc don't intend to make any additional comments regarding these negotiations unless and until it is appropriate to do so . Currently in discussions with Akorn concerning a potential acquisition of Akorn . Confirms that Fresenius Kabi is currently in discussions with Akorn Inc concerning a potential acquisition of Akorn .No assurance any transaction will result from these discussions or as to terms of any such transaction.  Full Article

Fresenius said to weigh a bid for U.S. generics maker Akorn - Bloomberg
Friday, 7 Apr 2017 

:Fresenius said to weigh a bid for U.S. generics maker Akorn - Bloomberg.  Full Article

Akorn reported Q2 EPS $0.50
Thursday, 4 Aug 2016 

Akorn Inc : Q2 GAAP earnings per share $0.50 . Q2 adjusted NON-GAAP earnings per share $0.58 including items . Akorn provides second quarter 2016 results . Q2 revenue $281 million versus i/b/e/s view $273 million . Sees FY 2016 revenue $1.06 billion to $1.08 billion . Q2 earnings per share view $0.55 -- Thomson Reuters I/B/E/S . Expects that full year GAAP earnings per share will be at upper end of previously communicated ranges of $1.56 - $1.66 . Expects that full year NON-GAAP earnings per share will be at upper end of previously communicated ranges of $2.10 - $2.20 . FY2016 earnings per share view $2.15, revenue view $1.08 billion -- Thomson Reuters I/B/E/S .Board of Directors authorizes $200 million stock repurchase program.  Full Article

Akorn Q1 earnings $0.34/shr
Tuesday, 17 May 2016 

Akorn Inc :Qtrly gaap eps of $0.34.  Full Article

Akorn affirms 2016 net revenue and EPS guidance
Tuesday, 10 May 2016 

Akorn Inc : Akorn completes 2014 financial statement restatement and reports audited 2015 and restated 2014 results . Affirms 2016 net revenue and earnings per share guidance .Announced plans to hold its 2016 annual meeting of shareholders on July 1, 2016.  Full Article

Akorn to file annual report for year ended Dec 31, 2015 on May 9
Saturday, 7 May 2016 

Akorn Inc :On Monday, May 9, 2016, company plans to file annual report on form 10-K for year ended December 31, 2015.  Full Article

Fresenius says Akorn deal closure could take until next year

FRANKFURT, Nov 22 German healthcare group Fresenius SE said the planned takeover of Akorn , a U.S. maker of liquid generic drugs, might not be completed before next year as the U.S. antitrust review could take longer than expected.